Clinical Trials
Novartis announces AMG 334 significantly reduces monthly migraine days in people with episodic migraine
Novartis announced positive topline results from ARISE, the first Phase III study evaluating the efficacy and safety of monthly subcutaneous AMG 334 (erenumab) 70mg...
Drug Research
Catalent Showcases Advanced Formulations, Development Technologies And Drug Delivery Solutions At CPhI Worldwide
Catalent Pharma Solutions (Booth 3J16), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced...
News
Zuellig Pharma to distribute imdur in eight markets for Topridge Pharma
Zuellig Pharma and TopRidge Pharma Limited have signed a deal that will see Zuellig Pharma distribute Imdur, a mature medicine for the prevention of...
Production & Manufacturing
FDA Approves Janssen’s STELARA for Treatment of Adults With Moderately to Severely Active Crohn’s Disease
Janssen Biotech Inc announced that the U.S. FDA has approved STELARA® (ustekinumab) for the treatment of moderately to severely active Crohn’s disease in adults...
Packaging & Labelling
ViscoTec expands presence in Switzerland
Trimaco Systeme GmbH from Zürich is distributing dosing and filling technology from ViscoTec in Switzerland from now on. With the new distribution partner the...
Packaging & Labelling
Marchesini Group At All4pack Paris
At All4Pack (14-17 November, Paris Nord Villepinte Exhibition Park) Marchesini Group will exhibit two stanBL A420 CW and Farplus C and a blister lined-alone...
Clinical Trials
Advaxis Inc starts New Manufacturing/Laboratory Facility in Princeton
Advaxis, Inc a clinical stage biotechnology company developing cancer immunotherapies, will unveil its new state-of-the-art manufacturing facility in Princeton, N.J., with remarks from Governor...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read